Latest News about Biotech
Recent news which mentions Biotech
Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
November 19, 2024
From Benzinga
EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential
November 19, 2024
From Benzinga
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
November 18, 2024
From Benzinga
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination
November 18, 2024
From Benzinga
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
November 18, 2024
From Benzinga
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
November 18, 2024
From Benzinga
Why Is Penny Stock HCW Biologics Surging On Monday?
November 18, 2024
From Benzinga
From Benzinga
JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
November 15, 2024
From Benzinga
From Benzinga
Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline
November 15, 2024
From Benzinga
Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
November 15, 2024
From Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
From Benzinga
Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue
November 15, 2024
From Benzinga
Robert Kennedy Poised To Lead Health And Human Services: Why FDA, NIH Officials Are Nervous
November 15, 2024
Tickers
NEWS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.